Fulcrum Therapeutics Inc. (FULC)
NASDAQ: FULC
· Real-Time Price · USD
7.50
0.12 (1.63%)
At close: Jun 27, 2025, 9:37 AM
1.63% (1D)
Bid | 7.39 |
Market Cap | 405.11M |
Revenue (ttm) | 80M |
Net Income (ttm) | -510K |
EPS (ttm) | -0.01 |
PE Ratio (ttm) | -750.5 |
Forward PE | n/a |
Analyst | Hold |
Ask | 7.67 |
Volume | 25,522 |
Avg. Volume (20D) | 562,901 |
Open | 7.43 |
Previous Close | 7.38 |
Day's Range | 7.34 - 7.54 |
52-Week Range | 2.31 - 10.13 |
Beta | 2.42 |
About FULC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FULC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FULC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+17.23%
Fulcrum Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
9 months ago
+15.27%
Fulcrum Therapeutics shares are trading higher after Pfizer withdrew its sickle cell treatment.